Fasting serum lipids and lipoprotein patterns were studied in 44 female survivors of acute myocardial infarction under the age of 45 years, and in 84 matched control subjects. Type II hyperlipoproteinaemina was present in 41 per cent of the myocardial infarction patients and in none of the controls. There was, however, no difference in the prevalence of the type IV abnormality, which was present in 7per cent of the myocardial infarction patients and 8 per cent of the control subjects. Mean cholesterol and triglyceride levels were both significantly higher in the women who had survived myocardial infarction than in the controls; the difference in triglyceride was attributable to the type IIb abnormality which occurred in iI per cent of these patients. It is suggested that ovarian hormones may protect premenopausal womenfrom type IVhyperlipoproteinaemia and its possible atherogenic sequelae.
Ischaemic heart disease is more common in men than in women, but this sex difference tends to become less with increasing age. In I970 the death rate from ischaemic heart disease in England and Wales was about seven times greater in men than in women in each of the io-year age groups from 25 to 54 years, but in those between 55 and 64 years there was only a threefold difference (Registrar-General's Statistical Review, I970). The higher incidence in older women, together with the observation that bilateral oophorectomy is associated with an increased risk of myocardial infarction (Parrish et young women who survived a myocardial infarct and in a group of matched controls.
Subjects and methods

Myocardial infarction patients
Myocardial infarction patients were identified in 2 of the 14 hospital regions of England and Wales which existed until reorganization of the Health Service -North West Metropolitan and Oxford. The study was confined to women under 45 years of age who were discharged from hospital during the years i968-72 after a proven diagnosis of myocardial infarction (according to the World Health Organization criteria for this diagnosis) (WHO, I97I). All patients included in the study either had unequivocal electrocardiographic evidence of myocardial infarction (i.e. development of a pathological Q wave or evolution of an injury current which lasted for more than one day), or a typical history of myocardial infarction together with raised serum enzymes and equivocal electrocardiographic changes. All acute hospitals in these areas with more than 300 beds were included in the investigation provided that a satisfactory manual diagnostic index (or a comparable computerized system) was available. There can be little doubt that occasional cases were missed when searching the manual indexes, but it seems unlikely that this could have introduced any element of bias. Sixty cases who fulfilled the study criteria were traced and an attempt was made to obtain a fasting blood sample from each of the patients. Samples able to obtain blood samples from 44 of the 6o cases (73%) and in every instance at least 6 months had elapsed between the time of the acute event and the time the blood sample was taken. Their mean age was 40 years and the range 25 to 44 years.
Controls
Three control patients, matched for age, marital status, and hospital of admission, were selected randomly for each myocardial infarct patient from a list of previously determined diagnoses which included a wide range of acute medical and surgical conditions and certain elective surgical procedures. The mean age and range were the same as for the infarct patients. An attempt was made to collect fasting blood samples from at least 2 of the 3 controls selected for each myocardial infarct patient and we succeeded in obtaining samples from 84 of these patients. As with the infarct patients, at least 6 months had elapsed between the time of discharge from hospital and the time the blood sample was taken.
Methods
Total serum cholesterol was measured by the method of Searcy and Bergquist (I960) and triglyceride by the method of Eggstein and Kreutz (I966) . Electrophoresis of lipoproteins was carried out on all samples on agarose gel by the method of Noble (I968). Lipid abnormalities were classified as recommended by the World Health Organization (a modification of the Fredrickson classification) (Beaumont et al., I970) . The upper limits of normal for both cholesterol and triglyeeride were set at twice the standard deviation above the mean for our control population. In view of the fact that the skewed distribution of serum triglyceride is normalized by logarithmic transformation (Carlson and Linstedt, I969) , all computations relating to this lipid were made with logarithms of the measured values. For clarity of presentation, however, the values obtained for the mean and upper limit of normal have been reconverted to the antilogarithms in Table i (Rifkind, Lowson, and Gale, I968) . The significance of differences between myocardial infarct patients and the control patients was calculated by the use of the Mann Whitney U test (Siegel, I956) .
The data presented in this paper were collected during the course of a study aimed at determining the relation between oral contraceptives and myocardial infarction (Mann et al., I975) . Oliver (1974) , who found hypercholesterolaemia to be present in 46 per cent of patients who had presented with myocardial infarction or angina.
Perhaps the most interesting finding in the present investigation is the fact that the type IV abnormality did not occur more frequently amongst the myocardial infarct patients than it did among their matched controls, as hypertriglyceridaemia, or type IV hyperlipoproteinaemia, has emerged as an important risk factor for ischaemic heart disease in men and older women in several restrospective studies (Goldstein et In order to attempt an explanation of the sex difference in ischaemic heart disease, it is helpful to consider the frequency of risk factors in men and women in the general population. A recent British investigation showed that both type II hyperlipoproteinaemia and hypertension had a similar prevalence among men and women. Type IV hyperlipoproteinaemia, on the other hand, was found to occur much more frequently in men (Lewis et al., I974b) . Brown and Daudiss (I973) found a similar sex difference in the prevalence of type IV hyperlipoproteinaemia in a free-living population in Albany, New York, and in addition noted a tendency for this difference to be less apparent in the 55 to 64 age group It is in this age group that the sex difference in death rates from ischaemic heart disease becomes less obvious (Registrar-General's Statistical Review, 1970) . Furthermore, there is no sex difference in ischaemic heart disease death rates in diabetes (Garcia et al., 1974) and while the diabetic state is associated with a wide range of metabolic abnormalities, hypertriglyceridaemia (and type IV hyperlipoproteinaemia) is the most frequently observed derangement of lipid metabolism (Nikkila and Kekki, I973). These observations suggest that ovarian hormones may exert at least some of their protective effect against ischaemic heart disease by protecting the premenopausal woman from hypertriglyceridaemia. In our study, type IV hyperlipoproteinaemia was present in only 7 per cent of the cases and 8 per cent of the controls, as compared with a frequency of 35 per cent in the cases of women over 45 studied in survivors of myocardial infarction. 
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